This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Japan’s pharmaceutical giant Takeda has entered a massive $1.7 billion collaboration with Iambic Therapeutics to accelerate the discovery of small-molecule drugs for cancer and inflammation, leveraging t
Wall Street is reeling as Anthropic’s latest "agentic" AI plugins trigger a massive sell-off, wiping out nearly $300 billion in market value from traditional software giants.
Tokyo Electron (TEL), a cornerstone of the global semiconductor supply chain, has significantly raised its full-year earnings forecast for 2026. The move is fueled by an insatiable global appetite for th
The historic $100 billion infrastructure partnership between Nvidia and OpenAI has hit a major snag as internal skepticism at Nvidia grows, leading to a shift toward a smaller equity-focused investment a
A major 2026 enterprise AI roundup reveals a growing skepticism among global leaders, with 56% of CEOs reporting that AI has yet to yield measurable revenue or cost benefits despite billions in investmen
BigBear.ai (BBAI) shares are witnessing high volatility as the company announces a landmark partnership with AD Ports Group. While initial gains were sharp, the stock has faced a downturn as traders weig
